Rania R Abdelaziz (Rania R Abdel-Aziz)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Inflammatory Response

Ischemia Reperfusion Injury

Rheumatoid Arthritis

Top Venues

Human & experimental toxicology

The Journal of pharmacy and pharmacology

Inflammopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed M Awad, Sally L Elshaer, Rajashekhar Gangaraju, Rania R Abdelaziz, Manar A Nader
Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways. Inflammopharmacology (2023)
Ahmed M Abo-Khookh, Hamdy A Ghoneim, Rania R Abdelaziz, Manar A Nader, Noha M Shawky
The dual inhibitor Sacubitril-valsartan ameliorate high-fat high-fructose-induced metabolic disorders in rats superiorly compared to valsartan only. The Journal of pharmacy and pharmacology (2023)
Mirhan N Makled, Mohammed S El-Awady, Rania R Abdelaziz, Ahmed B Shehab El-Din, Elsayed M Ammar, Nariman M Gameil
Pomegranate extract ameliorates renal ischemia/reperfusion injury in rats via suppressing NF-κB pathway. Human & experimental toxicology 40 (12_suppl) (2021)